Technology ID
E-072-2019-0

Therapeutic and Diagnostic Targets for Severe RSV Infection

Linked ID
TAB-3390
Inventors
Daniel Menendez Rendon (NIEHS)
Michael Resnick (NIEHS)
Steven Kleeberger (NIEHS)
Lead Inventors
Michael Resnick (NIEHS)
Co-Inventors
Daniel Menendez Rendon (NIEHS)
Steven Kleeberger (NIEHS)
Therapeutic Areas
Infectious Disease
ICs
NIEHS
Commercial Applications
  • Development of therapeutics against severe RSV infection
  • Diagnostic biomarker
Competitive Advantages
  • Enhance the innate immune response to respiratory infection
  • Improve clinical trial outcome in patients with TLR8 mediated RSV infection

Request More Info

Licensing Contact